Literature DB >> 6766802

Oligodendrogliomas. I. A clinical study of cerebral oligodendrogliomas.

H W Chin, J J Hazel, T H Kim, J H Webster.   

Abstract

Fifty-four patients with oligodendroglioma presented in the past 15 years. In contrast to some widely taught concepts, oligodendrogliomas occured largely in the frontotemporal area of both cerebral hemispheres with two peaks of age incidence: one small peak in childhood, and the highest incidence in the middle-aged adult. Seizures, either major and/or minor, were the most common clinical manifestations (average 87%). Cerebral angiography and pneumography were the most reliable and useful diagnostic procedures, as well as the promising CAT scan. All 24 patients who underwent combined modalities of treatment with radical surgery and postoperative radiation therapy survived at least five years, and 2 out of 11 patients treated by surgery alone failed to survive the five-year follow-up period in addition to two recurrences. Postoperative radiation treatment is considered quite effective and indicated in most cases because complete removal of the tumor is not always possible.

Entities:  

Mesh:

Year:  1980        PMID: 6766802     DOI: 10.1002/1097-0142(19800315)45:6<1458::aid-cncr2820450627>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

Review 1.  Radiation therapy for incompletely resected supratentorial low-grade glioma in adults.

Authors:  B Jeremic; M Bamberg
Journal:  J Neurooncol       Date:  2001-11       Impact factor: 4.130

2.  Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results.

Authors:  Ali Chahlavi; Andrew Kanner; David Peereboom; Susan M Staugaitis; Paul Elson; Gene Barnett
Journal:  J Neurooncol       Date:  2003-02       Impact factor: 4.130

3.  Hypoxia-inducible factor-1-regulated protein expression and oligodendroglioma patient outcome: comparison with established biomarkers and preoperative UCSF low-grade scoring system.

Authors:  Shirley Abraham; Nan Hu; Randy Jensen
Journal:  J Neurooncol       Date:  2012-03-06       Impact factor: 4.130

4.  Combined treatment modality for anaplastic oligodendroglioma: a phase II study.

Authors:  B Jeremic; Y Shibamoto; D Gruijicic; B Milicic; M Stojanovic; N Nikolic; A Dagovic; J Aleksandrovic
Journal:  J Neurooncol       Date:  1999-06       Impact factor: 4.130

5.  The prognostic implications of histologic classification and bromodeoxyuridine labeling index of mixed gliomas.

Authors:  M R Wacker; T Hoshino; D K Ahn; R L Davis; M D Prados
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 6.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

7.  The treatment of cerebral oligodendrogliomas with particular reference to features indicating malignancy: report of seventy-seven cases.

Authors:  M Turgut; K Tahta; O E Ozcan; B Onol
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

8.  Oligodendroglioma: an analysis of 42 cases.

Authors:  I M Wilkinson; J R Anderson; A E Holmes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

9.  Aggressive oligodendroglioma predicted by chromosome 10 restriction fragment length polymorphism analysis. Case study.

Authors:  J K Wu; R D Folkerth; Z Ye; B T Darras
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

Review 10.  The impact of technical adjuncts in the surgical management of cerebral hemispheric low-grade gliomas of childhood.

Authors:  M S Berger
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.